Envestnet Portfolio Solutions
PTCT icon

Envestnet Portfolio Solutions’s PTC Therapeutics PTCT Stock Holding History

Envestnet Portfolio Solutions’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.12M Buy
13,730
+237
+2% +$17.1K 0.01% 659
2026
Q1 		$919K Buy
+13,493
New +$955K 0.01% 661
2025
Q4 		– Sell
-3,454
Closed -$212K – 1540
2025
Q3 		$212K Buy
+3,454
New +$180K ﹤0.01% 1403

Other funds holding PTCT

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
PFC
Phocas Financial Corp Alameda, California $721M AUM 63.77% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Envestnet Portfolio Solutions's PTCT Position: Q2 2026 in Review

Envestnet Portfolio Solutions increased its PTC Therapeutics (PTCT) stake by 1.8% in Q2 2026, buying an estimated $17.1K and bringing the position to 13,730 shares worth $1.12M. The position accounts for 0.01% of the portfolio, ranked #659.

Envestnet Portfolio Solutions first reported a position in PTCT in Q3 2025 and has held it in 3 quarters since. 103 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Envestnet Portfolio Solutions held 13,730 shares of PTC Therapeutics worth $1.12M as of Q2 2026.
  • Envestnet Portfolio Solutions bought 237 PTC Therapeutics shares in Q2 2026, an estimated $17.1K.
  • PTC Therapeutics made up 0.01% of Envestnet Portfolio Solutions's portfolio in Q2 2026, its #659 holding.
  • Envestnet Portfolio Solutions first reported a position in PTC Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 103 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Envestnet Portfolio Solutions's 13F filing for Q2 2026, filed 20 Jul 2026.